Protected Nucleosides
5'-DMT-2'-O-hexadecyl-N4-acetylcytidine
Quick view. We supply 5'-DMT-2'-O-hexadecyl-N4-acetylcytidine as a DMTr-protected nucleoside intermediate for selective oligonucleotide building-block synthesis. CAS 2382942-37-0. Catalog target purity: Specification on request.
Structure and identity
The structure drawing for this item is being finalized. Use the CAS number and machine-readable identifiers below to confirm the requested protecting groups, stereochemistry, salt or counterion and hydration state before ordering.
CAS, molecular formula, SMILES or InChI data are shown below when available.
We withhold a drawing when a related compound, alternate salt or incompletely specified stereoisomer could be mistaken for the requested material.
Agreed identity and purity criteria are documented in the quotation, specification and lot-specific data package.
Product profile
5'-DMT-2'-O-hexadecyl-N4-acetylcytidine is classified as nucleoside or protected nucleoside intermediate (Formula C48H65N3O8; molecular weight 812.05).
5'-DMT-2'-O-hexadecyl-N4-acetylcytidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 5'-DMT-2'-O-hexadecyl-N4-acetylcytidine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- Cytidine, N-acetyl-5′-O-[bis(4-methoxyphenyl)phenylmethyl]-2′-O-hexadecyl-
Useful catalog search terms
- CAS 2382942-37-0
- Nucleoside or protected nucleoside intermediate
- DMTr/DMT protection
- Protected Nucleosides
Physicochemical data
| Key chemistry motifs | DMTr/DMT protection |
|---|---|
| Density | 1.14±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) |
| pKa | 10.20±0.20(predicted) |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
2'-O-TBDMS-rG(iBu)
Protected Nucleosides · CAS: 182007-86-9
BX-PN-00435'-O-DMTr-2'-O-TBDMS-rC(Ac)
Protected Nucleosides · CAS: 121058-85-3
BX-PN-00575'-O-TBDMS-3'-O-TBDMS-5-(hydroxymethyl)-dC
Protected Nucleosides · CAS: 1257247-39-4
BX-PN-00585'-O-TBDMS-3'-O-TBDMS-5-I-dC
Protected Nucleosides · CAS: 478843-96-8
BX-PN-00607'-O-TBDMS-4'-N-Trt-PMO-G(iBu)
Protected Nucleosides · CAS: N/A
BX-PN-00673'-O-TBDMS-2'-F-dG(iBu)
Protected Nucleosides · CAS: 2382967-92-0
Frequently asked questions
Can the package size for 5'-DMT-2'-O-hexadecyl-N4-acetylcytidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-PN-0215 and CAS 2382942-37-0, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Protected Nucleosides product family and its named chemistry.